🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎉Congrats to those 5 brilliant scientists from our Department of oncology!!! #cancerresearch Université de Lausanne Faculté de biologie et de médecine (inactif) CHUV / Centre hospitalier universitaire vaudois Johanna Joyce Solange Peters George Coukos HoLab John Haanen ▶️clarivate.com/highly-cited-r…

Amazing journey! Salut🫡

Thanks for the invitation from Society of Cancer Medicine and Ludwig Oxford Branch. I will share two new studies tomorrow. one is about metabolic targeting for HCC (from murine to human) and a compassionate therapy (reverse Pd1 resistance to responsive ones in NPC patients)🔥

Glad to visit Oxford and meet my Ludwig colleagues for dinner and discussion✌️Special thanks for Freddy Zippelius and Mariana Borsa (she/her) for being in my talk.

Amazing Stefania Vilbois got best presentation award. Another terrific PhD Kung-Chi Kao gave amazing talk in Japan and enjoy Asian cuisine with our postdoc #Tzu-Hsuan. What a wekk🎊 Ludwig Cancer Oncology UNIL CHUV

Looking for a #PhDposition? My lab & my colleagues IRB Barcelona are recruiting! You want to study how dendritic cells and #macrophages adapt to different environments? In a dynamic team with state-of-the-art approaches? We are waiting for you! Apply here➡️bit.ly/3OfbzSu

We are hiring! Work in Taiwan with an NIH-scale salary! Please RT!

iMetAct: An integrated systematic inference of metabolic activity for dissecting tumor metabolic preference and tumor-immune microenvironment dlvr.it/TJP2QP

It is a great journey to start from bench to bedside with my terrific collaborator-Huang-Yu. Thanks for Nature Metabolism and Ruoning for highlight our work. Ludwig Cancer Cancer Research Institute Swiss National Science Foundation

A fun process to jump into a new topic. By integrating phosphorylation regulome, iMetAct can better predict metabolic preference. Stay tuned for the next step about how we can integrate this with machine learning! Ludwig Cancer Cancer Research Institute

Congrats!!!! Joe is going to give a distinguished seminar at our institute in June. It gonna be exciting!

📢 Our department is looking to host a junior research group! We welcome expressions of interest from cancer researchers aiming to apply for funding through Ambizione, SNSF Starting Grants (StG), or ERC Starting Grants. Check the conditions here unil.ch/dof/en/home/me…

.Ana Belén Plata Gómez, PhD & HoLab review how aging& diet influence metabolic reprogramming of the tumor–immune microenvironment, contributing to cancer progression & immune evasion as well as strategies to restore antitumor immunity by targeting metabolic pathways hubs.la/Q03g_nzM0

A great piece from Ana Belén Plata Gómez, PhD ! Great support from Ludwig Cancer EMBO Cancer Research Institute

Joining my talk on Monday in AACR. I gonna present our journey from bench to bedside. Paper will be published simultaneously during my talk. We also just got pre-IND feedback! Let’s help cancer patients with more interventions!!! Ludwig Cancer Cancer Research Institute Oncology UNIL CHUV

It is a great journey from bench to bedside! It is also a fun process to collaborate with my formal trainees, Chin-Hsien and Sheue-Fen. Oncology UNIL CHUV Ludwig Cancer Cancer Research Institute

Having a great time in Chicago for AACR 2025. Looking forward to share with everyone another new direction/work we explored in 10 days✌️

Joining us for this wonderful event in beautiful Lausanne!

Check out our new review with my amazing postdoc and formal trainee. A new topic and direction! #tumorimmunology #lymphnode Thanks the support from Ludwig Cancer Cancer Research Institute Oncology UNIL CHUV kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Second paper in a day🫶 Checking out the work of Jhan-Jie Peng, a terrific co-mentored student. CAR T cells against autoantibody producing B cells published in Science Immunology ! Thanks for the supports from Ludwig Cancer Cancer Research Institute Oncology UNIL CHUV . science.org/doi/10.1126/sc…